SXTC fundamentals
An in-depth look to China SXT Pharmaceuticals, Inc. operating, investing, and financing activities
SXTC free cash flow for H1 23 is -579.57 k USD. For 2022, SXTC free cash flow was -151.44 k USD and operating cash flow was -80.76 k USD.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
TTM